Evidence map›Paper›PMID 36644227›Full record

ArticleDrug and alcohol dependence reports2022

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment.

Yue Pan, Daniel J Feaster, Gabriel Odom, Laura Brandt, Mei-Chen Hu, Roger D Weiss, John Rotrosen, Andrew J Saxon, Sean X Luo, Raymond R Balise

Open access · goldAbstract read
In one paragraph

Article in Drug and alcohol dependence reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Are you thinking what I'm thinking? Defining what we mean by "polysubstance use."The American journal of drug and alcohol abuse · 2024
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Yue PanDepartment of Public Health Sciences, Division of Biostatistics, University of Miami, Office 1023, 1120 NW 14th St, Miami, FL 33136, USA.
Daniel J FeasterDepartment of Public Health Sciences, Division of Biostatistics, University of Miami, Office 1023, 1120 NW 14th St, Miami, FL 33136, USA.
Gabriel OdomDepartment of Biostatistics, Florida International University, USA.
Laura BrandtDepartment of Psychology, The City College of New York, USA.
Mei-Chen HuDepartment of Psychiatry, Columbia University, USA.
Roger D WeissDepartment of Psychiatry, Harvard Medical School, Boston, and McLean Hospital, USA.
John RotrosenDepartment of Psychiatry, NYU Grossman School of Medicine, USA.
Andrew J SaxonDepartment of Psychiatry and Behavioral Sciences, University of Washington, USA.
Sean X LuoDepartment of Psychiatry, Columbia University, USA.
Raymond R BaliseDepartment of Public Health Sciences, Division of Biostatistics, University of Miami, Office 1023, 1120 NW 14th St, Miami, FL 33136, USA.
University of Miami · USColumbia University · USCity College of New York · USFlorida International University · USHarvard University · USNew York University · USUniversity of Washington · US

Funding

Project-003UG1DA013035 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Aimee N Campbell, Jennifer McNeely · 2015 to 2026
$130.3M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
NIDA NIH HHS T32 DA037801NIDA NIH HHS U10 DA013720NIDA NIH HHS UG1 DA013035NIDA NIH HHS UG1 DA013720
6 · The paper itself

Abstract

Introduction: While polysubstance use has consistently been associated with higher rates of relapse, few studies have examined subgroups with specific combinations and time course of polysubstance use (i.e., polysubstance use patterns). This study aimed to classify and compare polysubstance use patterns, and their associations with relapse to regular opioid use in 2637 participants in three large opioid use disorder (OUD) treatment trials. Methods: We explored the daily patterns of self-reported substance use in the 28 days prior to treatment entry. Market basket analysis (MBA) and repeated measure latent class analysis (RMLCA) were used to examine the subgroups of polysubstance use patterns, and multiple logistic regression was used to examine associations between identified classes and relapse. Results: MBA and RMLCA identified 34 "associations rules " and 6 classes, respectively. Specific combinations of polysubstance use and time course (high baseline use and rapid decrease of use prior to initiation) predicts a worse relapse outcome. MBA showed individuals who co-used cocaine, heroin, prescription opioids, and cannabis had a higher risk for relapse (OR = 2.82, 95%CI = 1.13, 7.03). In RMLCA, higher risk of relapse was observed in individuals who presented with high baseline prescription opioid (OR = 1.9, 95% CI = 1.3, 2.76) or heroin use (OR = 3.54, 95%CI = 1.86, 6.72), although use decreased in both cases prior to treatment initiation. Conclusions: Our analyses identified subgroups with distinct patterns of polysubstance use. Different patterns of polysubstance use differentially predict relapse outcomes. Interventions tailored to these individuals with specific polysubstance use patterns prior to treatment initiation may increase the effectiveness of relapse prevention.

Indexed as

CocaineMarket basketOpioidsOpioid use disorderPolysubstance useRepeated latent class analysis

Identifiers

PMID36644227
PMCPMC9838120
OpenAlexW4310718211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.